S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
With oil prices slumping, OPEC+ producers weigh more production cuts
66,000% upside on tiny biotech? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
66,000% upside on tiny biotech? (Ad)
Chuck Todd says he's leaving 'Meet the Press' after a tumultuous near-decade moderating the NBC political panel show
Chuck Todd leaving NBC political panel show 'Meet the Press' and being replaced by Kristen Welker
NYSE:CNMD

CONMED (CNMD) Stock Forecast, Price & News

$126.81
+3.02 (+2.44%)
(As of 06/2/2023 ET)
Compare
Today's Range
$123.24
$126.89
50-Day Range
$114.11
$128.18
52-Week Range
$71.09
$129.65
Volume
446,474 shs
Average Volume
304,010 shs
Market Capitalization
$3.88 billion
P/E Ratio
N/A
Dividend Yield
0.63%
Price Target
$130.40

CONMED MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
2.8% Upside
$130.40 Price Target
Short Interest
Bearish
13.44% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.74
Upright™ Environmental Score
News Sentiment
0.99mentions of CONMED in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$7.78 M Sold Last Quarter
Proj. Earnings Growth
26.39%
From $3.41 to $4.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

826th out of 983 stocks

Electromedical Equipment Industry

17th out of 22 stocks


CNMD stock logo

About CONMED (NYSE:CNMD) Stock

CONMED Corp. operates as a medical technology company, which engages in the development, manufacturing, and sale of surgical devices and related equipment. It operates through the United States, Europe, Middle East, and Africa, and Asia Pacific geographical segments. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

CNMD Stock News Headlines

CL King Initiates Coverage on CONMED (NYSE:CNMD)
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Conmed: Updated Guidance Is Positive
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
CONMED Co. (NYSE:CNMD) EVP Sells $312,576.00 in Stock
CONMED (NASDAQ:CNMD) Upgraded to "Hold" at StockNews.com
CONMED (NYSE:CNMD) Trading Up 6.9% After Strong Earnings
CONMED (NYSE:CNMD) Upgraded at StockNews.com
See More Headlines

CNMD Price History

CNMD Company Calendar

Ex-Dividend for 4/5 Dividend
3/14/2023
Dividend Payable
4/05/2023
Last Earnings
4/26/2023
Today
6/04/2023
Ex-Dividend for 7/5 Dividend
6/14/2023
Dividend Payable
7/05/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Employees
4,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$130.40
High Stock Price Forecast
$140.00
Low Stock Price Forecast
$119.00
Forecasted Upside/Downside
+2.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-80,580,000.00
Pretax Margin
-7.82%

Debt

Sales & Book Value

Annual Sales
$1.05 billion
Cash Flow
$5.36 per share
Book Value
$24.61 per share

Miscellaneous

Free Float
28,251,000
Market Cap
$3.88 billion
Optionable
Optionable
Beta
1.38

Key Executives

  • Curt R. HartmanCurt R. Hartman
    Chairman, President & Chief Executive Officer
  • Todd W. GarnerTodd W. Garner
    Chief Financial Officer & Executive Vice President
  • Shanna L. Cotti-Osmanski
    Chief Information Officer & Executive VP-IT
  • Terence M. Bergé
    Vice President & Controller
  • Bill Peters Peters
    Vice President & General Manager-Advanced Surgical













CNMD Stock - Frequently Asked Questions

Should I buy or sell CONMED stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CNMD shares.
View CNMD analyst ratings
or view top-rated stocks.

What is CONMED's stock price forecast for 2023?

4 analysts have issued 1 year target prices for CONMED's shares. Their CNMD share price forecasts range from $119.00 to $140.00. On average, they anticipate the company's share price to reach $130.40 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price.
View analysts price targets for CNMD
or view top-rated stocks among Wall Street analysts.

How have CNMD shares performed in 2023?

CONMED's stock was trading at $88.64 at the beginning of 2023. Since then, CNMD stock has increased by 43.1% and is now trading at $126.81.
View the best growth stocks for 2023 here
.

When is CONMED's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CNMD earnings forecast
.

How were CONMED's earnings last quarter?

CONMED Co. (NYSE:CNMD) issued its earnings results on Wednesday, April, 26th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.06. The firm had revenue of $295.47 million for the quarter, compared to the consensus estimate of $266.66 million. CONMED had a positive trailing twelve-month return on equity of 11.38% and a negative net margin of 8.53%. The business's quarterly revenue was up 21.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.70 EPS.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Wednesday, May 24th. Shareholders of record on Thursday, June 15th will be paid a dividend of $0.20 per share on Wednesday, July 5th. This represents a $0.80 annualized dividend and a yield of 0.63%. The ex-dividend date is Wednesday, June 14th.
Read our dividend analysis for CNMD
.

Is CONMED a good dividend stock?

CONMED (NYSE:CNMD) pays an annual dividend of $0.80 per share and currently has a dividend yield of 0.65%.
Read our dividend analysis for CNMD.

What guidance has CONMED issued on next quarter's earnings?

CONMED updated its FY 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share guidance of $3.30-$3.50 for the period, compared to the consensus earnings per share estimate of $3.32. The company issued revenue guidance of $1.21 billion-$1.25 billion, compared to the consensus revenue estimate of $1.19 billion.

What is CONMED's stock symbol?

CONMED trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNMD."

Who are CONMED's major shareholders?

CONMED's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.09%), Ameriprise Financial Inc. (4.42%), State Street Corp (3.81%), Champlain Investment Partners LLC (3.22%), Principal Financial Group Inc. (2.61%) and Macquarie Group Ltd. (2.50%). Insiders that own company stock include Brian Concannon, Daniel S Jonas, Johonna Marie Pelletier, Peter K Shagory, Stanley W Peters III and Todd W Garner.
View institutional ownership trends
.

How do I buy shares of CONMED?

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $126.81.

How much money does CONMED make?

CONMED (NYSE:CNMD) has a market capitalization of $3.88 billion and generates $1.05 billion in revenue each year. The company earns $-80,580,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis.

How many employees does CONMED have?

The company employs 4,100 workers across the globe.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The official website for the company is www.conmed.com. The company can be reached via phone at (727) 392-6464 or via fax at 315-797-0321.

This page (NYSE:CNMD) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -